1 Data as of March 31, 2023. Accredited Investors is based on accredited investors in the Bioverge Network. Realized Net IRR (internal rate-of-return) is net of fees and expenses. MOIC (multiple-on-invested capital) is gross, before taking into account fees and expenses. Realized Net IRR and Realized MOIC are realized values based on the performance of all exits and write-downs or liquidation events, and are limited to companies within our portfolio that have had an exit event or have been shut down, or are otherwise no longer operating. Realized Net IRR and Realized MOIC are based on distributions calculated at the time of transaction close, and include escrows and amounts receivable at a future date but do not include contingent compensation that may not be realized. Realized Net IRR and Realized MOIC may be higher or lower due to the impact of market fluctuations for publicly held securities and the impact of the timing of distributions. Results are not audited. Past performance is not indicative of future results. Back

2 Data as of March 31, 2023. Returns shown for each Access Fund reflect the fair market value of investments as determined in good faith by Bioverge according to our stated valuation policy (see Investor Disclosure for additional information). Unrealized investments are recorded at cost, and are only re-valued upon consummation of an arms-length transaction, either an Up-round or Down-round in a portfolio company, in accordance with this policy, or written off as a total loss if Bioverge so determines. Up-round generally means a financing subsequent to Bioverge’s investment has occurred at a higher per-share valuation (more favorable) than our original investment. Downround generally means a subsequent financing has occurred at a lower per-share valuation (less favorable) than our original investment. Realized values are based upon an amount received in the event of an Exit (such as an acquisition by an acquirer) or an initial public offering (IPO), or similar proceeds. Exits are based on gross distributions available at the time a transaction closed and include escrows and amounts receivable at a future date but do not include contingent compensation that may not be realized. Unrealized MOIC and Unrealized IRR are metrics describing the total Fair Market Value (FMV) or “paper valuation” of the investments. This includes realized distributions already paid out and unrealized changes to a company’s valuation based upon a closed financing round and includes probability-adjusted future milestone payments. Except for realized returns, there is no assurance that any additional value can be obtained in the future. Back

Not an Offer to Sell or Solicitation to Buy
The information presented on this Website does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities of Bioverge. Any such offer would only be made through of a prospectus, private placement memorandum, subscription agreement or similar documents. This Website is subject to material updating, revision and further amendment.

Conduct Your Own Due Diligence
This information is not intended to provide the sole basis for your evaluation of Bioverge. You should conduct your own due diligence of Bioverge and independently verify the information contained below before proceeding further with any investment in or other transaction with Bioverge. Our officers will make themselves available to answer any questions that you may have regarding our company, its business, operations and prospects should you decide to proceed further with an investment or other transaction with Bioverge.

Forward Looking Statements
The information set forth below includes statements, estimates, projections with respect to our anticipated future performance and other forward-looking statements, which are subject to risks, uncertainties and assumptions. In some cases, you can identify these statements by forward-looking words such as “may”, “might”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “future” or “continue”, the negative of these terms and other comparable terminology. Such forward-looking statements are based on current plans, estimates and expectations and are made pursuant to the Private Securities Litigation Reform Act of 1995. These statements, estimates and projections are based upon various assumptions that we made concerning our anticipated results and industry trends, which may or may not occur. We are not making any representations as to the accuracy of these statements, estimates or projections. Our actual performance may be materially different from the statements, estimates or projections set forth below. We are under no duty to update any of these forward-looking statements to conform them to actual results or revised expectations. Back